FindMyKOL
Clinical trialNCT03981822CompletedPhase 2Interventional

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

SponsorVerrica Pharmaceuticals Inc.Enrollment105Condylomata AcuminataPapillomavirus InfectionsSexually Transmitted DiseasesSexually Transmitted Diseases, ViralSkin DiseasesSkin Diseases, Infectious+2 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase 2, double-blind, placebo-controlled study to determine the dose regimen, safety, tolerability, and efficacy of VP-102 in subjects with External Genital Warts (EGW). This study is divided into two parts (Part A and Part B). Increasing durations of skin exposure to study drug (VP-102 or placebo) will be evaluated in three treatment groups prior to progressing to enrollment in Part B. Part A \& B will enroll a approximately 108 subjects completing 4 treatment applications every 21 days and continuing with follow-up assessments at Day 84, 112 and 147.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the Indiana Clinical Trials Center,pc

    Plainfield, Indiana, United States

  • Delricht Research

    Baton Rouge, Louisiana, United States

  • Clarkston Skin Research

    Clarkston, Michigan, United States

  • Delricht Research

    Tulsa, Oklahoma, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Jun 2019
Primary completion
21 May 2020
Completion
8 Jul 2020
Last update posted
27 Nov 2024
Registered enrollment
105
Registry id
NCT03981822
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.